Hemophagocytic Lymphohistiocytosis in a Patient with Rheumatoid Arthritis on Pembrolizumab for Lung Adenocarcinoma

Immune checkpoint inhibitors have changed the landscape of classic cancer treatment. However, their use is associated with the emergence of new adverse events. An elderly man with rheumatoid arthritis was started on pembrolizumab for newly diagnosed advanced lung cancer. He subsequently developed he...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Intern Med
Autori principali: Akagi, Yu, Awano, Nobuyasu, Inomata, Minoru, Kuse, Naoyuki, Tone, Mari, Yoshimura, Hanako, Jo, Tatsunori, Takada, Kohei, Kumasaka, Toshio, Izumo, Takehiro
Natura: Artigo
Lingua:Inglês
Pubblicazione: The Japanese Society of Internal Medicine 2020
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7205536/
https://ncbi.nlm.nih.gov/pubmed/32009093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.3889-19
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi